Justine Kahn, MD
I am a pediatric oncologist at Columbia University Medical Center specializing in cancer care delivery, health disparities and survival outcomes in children and adolescents with hematologic malignancies, specifically Hodgkin and non-Hodgkin lymphoma (HL) and acute lymphoblastic leukemia (ALL). I received my MD from the Icahn School of Medicine at Mount Sinai in New York and completed my pediatric residency at Mount Sinai Kravis Children’s Hospital. I completed my pediatric hematology/oncology fellowship at NY-Presbyterian/Columbia University Medical Center. I am currently working toward obtaining a Masters of Science in Patient Oriented Research through Columbia University’s Mailman School of Public Health.
In collaboration with my colleagues, I conduct both clinical trials and large database investigations through studies developed in the Children's Oncology Group (COG) and in the Dana-Farber Cancer Institute (DFCI) ALL Consortium. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the U.S. I have chosen to focus my research efforts on minority and underserved patient populations because studies suggest that poor access to care, low health literacy, treatment non-adherence and financial stress can all negatively impact survival in children with cancer. As pediatric oncology providers we seek to cure every single child we meet. Understanding how social determinants of health contribute to pediatric cancer outcomes is an essential step toward achieving this goal.
My current research is supported in part by a grant from the Lymphoma Research Foundation as well as by a training grant from the National Cancer Institute (PI: A. Neugut).
"Where systematic differences in health are judged to be avoidable by reasonable action, they are, quite simply, unfair. It is this that we label health inequity. Putting right these inequities – the huge and remediable differences in health within and between countries – is a matter of social justice, and reducing health inequities is an ethical imperative."
The World Health Organization Commission on Social Determinants of Health, 2005
As of 2016, Dr. Kahn is supported by a training grant from the National Cancer Institute (NCI) (R25 Training Grant in Cancer Related Population Sciences), as well as a young investigator award from the Lymphoma Research Foundation (Lymphoma Research Foundation Clinical Research Mentoring Program). She will complete a Master of Science in Patient Oriented Research at the Columbia University Mailman School of Public Health in 2018. Her research focus is on using large databases to examine health outcomes and survival disparities in children and adolescent/young adult patients with hematologic malignancies. Dr. Kahn's research is aimed at understanding how differences in access to high-quality cancer care impact survival outcomes in underserved patient populations. She is also interested in how access differences impact survivorship care for patients who complete therapy. At present Dr. Kahn is conducting both clinical and large database investigations through studies with the Children's Oncology Group (COG), the Dana-Farber Cancer Institute (DFCI) Pediatric ALL Consortium, and the New York State Cancer Registry.